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Ab s t r a c t
Introduction: The aim of the study was to assess the relation of baseline
mechanical dyssynchrony with the left ventricular end-systolic volume (LVESV)
decrease following cardiac resynchronization (CRT) therapy introduction.
Material and methods: Sixty consecutive patients (aged 66.3 ±8.7 years; 57 men)
with chronic heart failure (71.7% of ischaemic and 28.3% of non-ischaemic origin)
and current indications for CRT were assessed before and 3 months after
biventricular heart stimulator implantation. Longitudinal movements of twelve
segments of the left ventricle (LV) (6 basal and 6 midlevel) and two segments
of the right ventricle (RV) were analysed using tissue Doppler imaging (TDI)
techniques with time from onset of Q wave in ECG to peak systolic velocity in
colour-coded TDI (TTDI), time to peak strain (Tstrain) and time to peak strain rate
(Tstrain rate). Minimal and maximal time differences within LV and between LV
and RV walls were calculated.
Results: In the study group LVEF and 6-min walk test distance increased, while
NYHA class, NT-proBNP level, left ventricular end-diastolic volume and LVESV
decreased. Significant correlations between the magnitude of LVESV reduction
with maximal time differences between Tstrain of 12 LV segments (r = 0.34, 
p = 0.017) and time differences between TTDI basal LV-RV segments (r = –0.29,
p = 0.041) were found.
Conclusions: Only a few TDI-derived parameters such as maximal time
differences between Tstrain of 12 LV segments and TTDI difference of LV-RV basal
segments can be useful to predict the magnitude of left ventricle reverse
remodelling after CRT introduction.
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Introduction
Cardiac resynchronization therapy (CRT) has a well-established position
in the treatment of drug-refractory chronic heart failure (CHF) [1, 2]. The
CRT improves filling of the left ventricle, increases ejection fraction (LVEF),
cardiac output and systolic blood pressure, reduces mitral insufficiency
and, in long-term observations, induces left ventricle reverse remodelling.
The CRT was also found to decrease sleep-related breathing disorders that
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augment CHF, improve the function of the
autonomic nervous system and lead to a fall of
some inflammatory markers [3-6]. Solid evidence
from clinical trials has proven that CRT amends
physical capacity and quality of life, and decreases
morbidity and mortality related to CHF. Unfor -
tunately, a considerable proportion (30-40%) of
individuals undergoing CRT in clinical trials did not
benefit from this novel therapy [7]. Since the
absence of echocardiographic dyssynchrony is
associated with a less favourable CRT outcome, the
answer to the question of CRT failure is also
believed to be found in the complex heart
mechanical performance [8]. A debate on the issue
has been triggered with echocardiographic
researchers from around the world contributing
volubly to the discussion.
The aim of this study was to assess the relation
of baseline mechanical dyssynchrony in the
echocardiographic study with the use of tissue
Doppler imaging (TDI), strain and strain rate
parameters with the left ventricle reverse
remodelling observed after CRT implantation,
a powerful long-term prognostic factor, in typical
daily practice CHF patients receiving biventricular
heart stimulation [9, 10]. A unique approach in the
analysis of CRT outcome was engaged: the
presence of at least 10% relative left ventricular
end-systolic volume (LVESV) reduction or the
magnitude of LVESV decrease following biven -
tricular heart stimulator was considered.
Material and methods
Study group
Seventy-two consecutive patients with chronic
heart failure in NYHA class III-IV stable for at least
3 months despite optimized pharmacotherapy, with
left ventricle end-diastolic diameter (LVEDd) 
> 55 mm, left ventricular ejection fraction (LVEF) 
≤ 35% and wide QRS complex (≥ 120 ms), were
involved in the prospective study. Eight individuals
met the exclusion criteria, two refused to have CRT
introduced, and in another two implantation of the
left ventricular lead did not succeed. Eventually 
60 patients (aged 66.3 ±8.7 years, 57 men [95%], 
3 women [5%]) participated in the study. 
Exclusion criteria
Exclusion criteria comprised the presence of
unstable angina, acute myocardial infarction,
coronary artery bypass graft or percutaneous
coronary intervention within 3 months; continuous
or intermittent intravenous inotropic drug therapy,
an estimated life expectancy of less than 12
months, a mechanical right-side heart valve, heart
transplant, pregnancy or concurrent enrolment in
a study thought to confound the results. 
Study design
Before CRT implantation and at 3 months of the
follow-up (12-16 weeks) individuals were evaluated
clinically with NYHA class, 6-min walk test (6-MWT),
history with questions about hospitalizations and
echocardiographically. Criteria of diagnosis of
different clinical and biochemical disorders were
adopted from the European Society of Cardiology
(ESC) guidelines [1]. All patients undergoing CRT
had had coronarography done. Ischaemic
background of CHF was diagnosed when there was
at least 50% stenosis of one or more coronary
artery branches or a patient had a history of
coronary artery bypass graft (CABG) or percu -
taneous coronary intervention (PCI) [11, 12].
Informed consent was obtained from each
patient. The study protocol conforms to the ethical
guidelines of the 1975 Declaration of Helsinki and
was accepted by the Jagiellonian University Medical
College Bioethical Committee.
Biventricular device implantation
Patients in sinus rhythm received an atrio-
biventricular stimulator (DDDR BiV – n = 47), while
individuals with permanent atrial fibrillation
received a biventricular device (VVIR BiV – n = 13).
Patients with a history of cardiac arrest and/or
malignant ventricular arrhythmias had the system
with combined cardioverter-defibrillator (CRT-D)
implanted (18 cases). During CRT all leads were
implanted transvenously. The left ventricular lead,
guided by a venogram, was placed in a coronary
sinus tributary in a stable lateral or postero-lateral
position, with a < 3.5 V capture threshold. The right
ventricular lead was placed in the septal or outflow
tract (RVOT) position. Positions of lead tips were
verified on frontal and sagittal chest X-ray. Two
patients required left ventricular lead repositioning
due to their dislocation. Atrioventricular (AV) delay
remained standard programmed 150/120 ms, unless
conduction of cardiotopic systoles was preserved.
In those patients AV was shortened until ventricles
were paced (5 cases). Interventricular (VV) timing
left nominal 5 ms, unless no signs of biventricular
stimulation in the body surface ECG were observed.
VV was changed then to elicit the picture of QRS
fusion beats in ECG lead V1 (7 cases) like in the
study of Bailey et al. [13]. Such a VV-delay optimi -
zation was there proven to correlate better with
maximum rate of rise of left ventricular pressure
(dp/dtmax) than the strategy to obtain the narrowest
paced QRS complexes. 
In patients with permanent atrial fibrillation,
ventricles' rate control with β-blockers and digoxin
was assessed. In one patient an unsatisfactory
pharmacologic effect (< 95% of biventricular
stimulation) was observed and ablation of the
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atrioventricular junction was performed. The follow-
up was prolonged over 3 months after the
procedure. 
Echocardiography
Echocardiographic examinations were
performed with the apparatus Vivid 7 (General
Electric Healthcare). Left ventricular volumes and
LVEF were evaluated using biplane Simpson's
method. All stored echo recordings were analysed
off-line by means of the Echo Pack system with GE
brand software by an experienced physician with
respect to the echocardiography norms of the
European Association of Echocardiography and
recommen dations of the American Society of
Echocardio graphy (ASE) for performance and
reporting of echocardiographic studies for CRT
[14, 15]. A different approach from the ASE
recommen dations regarded four aspects. Patients
with atrial fibrillation were included – analysis of
atrial fibrillation was done on at least 5-beat
sequences of 60-80 bpm rate. The search for the
desired peak TDI, strain rate and strain was not
limited to the parts of curves within the time when
the aortic valve was open. Multipeak curves with
peaks of similar height were excluded from the
analysis. Each single myocardial wall was recorded
separately (not in sets of two opposite walls) in
order to record longitudinal segments’ movements
along scan lines and reduce the Doppler angle
dependent bias. 
Longitudinal movements of twelve segments of
the left ventricle (LV) (6 basal and 6 midlevel) and
two segments of the right ventricle (RV) were
analysed using tissue Doppler imaging (TDI)
techniques with times from onset of Q wave in ECG
to peak systolic velocity in colour-coded TDI (TTDI),
time to peak strain (Tstrain) and time to peak strain
rate (Tstrain rate). Standard deviations (SD) of times
of LV segments were calculated, and minimum and
maximum time differences among LV segments as
well as LV and RV walls in these different
techniques were analysed. 
The following dyssynchrony indices were
calculated:
1) T-SD – standard deviation of time from the
beginning of QRS complex to maximum systolic
velocity/strain/strain rate among 12 left ventricle
segments,
2) T-12 – maximum difference of time from the
beginning of QRS complex to maximum systolic
velocity/strain/strain rate among 12 left ventricle
segments (basal and midlevel),
3) T-6-basal – maximum difference of time from the
beginning of QRS complex to maximum systolic
velocity/strain/strain rate among 6 basal left
ventricle segments,
4) T-IVS- free wall – maximum difference of time
from the beginning of QRS complex to maximum
systolic velocity/strain/strain rate between basal
and midlevel septal segments (septal and antero-
septal segments) and left ventricle free wall
(lateral and posterior segments),
5) T-basal IVS-free wall – maximum difference of
time from the beginning of QRS complex to
maximum systolic velocity/strain/strain rate
between basal septal segments (septal and
antero-septal segments) and left ventricle free
wall (lateral and posterior segments),
6) T-IVD – maximum difference of time from the
beginning of QRS complex to maximum systolic
velocity/strain/strain rate between basal left
ventricle and right ventricle segments.
Echocardiographic recordings interpretation
limitations 
Poor image quality and the ambiguity of
interpretation of the obtained curves caused that
26.4% of TDI, strain rate and strain parameters were
incalculable. Based on the analysis of 10 ran domly
chosen recordings, intra-observer variability for
LVESV estimation was 4 ±3%, for peak systolic
velocity – 7 ±10%, for peak systolic strain – 9 ±12%
and for peak systolic strain rate – 9 ±11%.
The CRT outcome assessment 
Patients with at least 10% relative reduction of
LVESV after 3 months of the follow-up were
classified as responders to CRT. Clinical and
echocardiographic parameters were compared
between these two groups. In the second part of
the analysis correlations between TDI-derived
variables and the magnitude of reverse remodelling
as a CRT outcome measure were appraised. 
Statistical analysis
Statistical analysis was performed within SAS
System 9.1 (SAS Institute Inc., Cary North Carolina,
USA) by Student’s t-test, Fisher’s exact test and χ2
test. The PROC CORR procedure was applied to
assess correlations. Statistical significance was
considered when p < 0.05. Data are expressed as
mean (± SD) for continuous variables and as
absolute frequencies or relative percentages for
categorical variables.
Results
Clinical characteristics of the study group
In the study group 61.6% were in sinus rhythm,
16.7% had paroxysmal atrial fibrillation and 21.7%
permanent fibrillation. Conduction disorders
constituted left bundle branch block (65.0%), right
bundle branch block (1.7%), and ventricular
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conduction disturbances of other morphology
(33.3%). Two patients with previously implanted
ventricular heart stimulator (VVI), 9 with dual
chamber pacemaker (DDD) and 3 with dual
chamber implantable cardioverter-defibrillator
(DDD-ICD) had their systems upgraded to CRT.
Clinical characteristics of the study group are
summarized in Table I.
Course of the study
Three patients died in the 3-month-follow-up:
one of stroke, one of myocardial infarction, and one
suddenly at home of unknown cause. These
individuals were excluded from the further analysis.
In the observation period 10 patients were
hospitalized, 7 of them due to CHF exacerbation.
All prescriptions (medications – see Table I)
remained stable through the study.
Effects of CRT
In the whole study group LVEF increased, 6-MWT
distance rose, and left ventricular end-diastolic
volume (LVEDV) and LVESV decreased. Mean NYHA
class and QRS width diminished (Table II). Results
of specialized examinations before and after
implementation in the studied subgroups of
responders (n = 34, 59.7%) and non-responders to
CRT (n = 23, 40.3%) are shown in Table III.
Clinical and classic echocardiographic features
Responders did not differ from non-responders
in respect of baseline left ventricular end-diastolic
and end-systolic diameters and volumes, or the size
of mitral regurgitation (Table III). 
Baseline dyssynchrony echocardiographic
indices and CRT outcome
In the analysis of colour-coded TDI, myocardial
strain rate and strain indices, the only parameter
that differentiated the groups with and without
reverse remodelling was Tstrain of 12 LV segments
(Table IV). Significant correlations between the
magnitude of LVESV reduction with maximal time
differences between Tstrain of 12 LV segments and
time differences between TTDI basal LV-RV segments
were found (Table V, Figure 1).
Multivariate analysis
In the multivariate analysis, variables that
differentiated the groups with and without ≥ 10%
Parameter All (n = 60) Responders (n = 34) Non-responders (n = 23) Value of p
Age [years] 66.3 (8.7) 65.8 (8.2) 67.1 (9.4) 0.60
Gender – male [%] 57 (95%) 33 (97%) 24 (92%) 0.57
BMI [kg/m2] 26.1 (4.3) 26.0 (3.0) 27.0 (5.0) 0.33
NYHA 3.1 (0.2) 3.1 (0.3) 3.1 (0.2) 0.91
Ischaemic aetiology of CHF 43 (71%) 21 (62%) 22 (84%) 0.04
Permanent atrial fibrillation 13 (22%) 6 (18%) 7 (27%) 0.048
Diabetes type 2 25 (42%) 12 (35%) 13 (50%) 0.30
Chronic obstructive pulmonary disease 11 (18%) 7 (21%) 4 (15%) 0.52
Hypercholesterolaemia 46 (76%) 26 (76%) 20 (76%) 0.99
Anaemia 2 (3%) 2 (6%) 0 (0%) 0.35
CRT-D 18 (30%) 11 (32%) 7 (27%) 0.56
History of stroke 4 (6.7%) 3 (9%) 1 (3%) 0.62
Chronic renal disease 20 (33.3%) 8 (23%) 12 (46%) 0.09
Medication 
ACEI/ARB 51 (85%) 30 (88%) 21 (81%) 0.48
β-Blocker 58 (96.7%) 33 (97%) 25 (96%) 0.99
Loop diuretic 53 (88.3%) 28 (82%) 25 (96%) 0.12
Potassium-sparing diuretic 40 (66.7%) 25 (73%) 15 (58%) 0.27
Digoxin 13 (21.7%) 8 (23%) 5 (19%) 0.76
Amiodarone 18 (30%) 9 (26%) 9 (35%) 0.39
CRT-D – cardiac resynchronization therapy defibrillator, ACEI – angiotensin converting enzyme inhibitor, ARB – angiotensin receptor blocker
Table I. Baseline clinical data of the whole study group and of responders and non-responders subgroups according
to the applied criterion of at least 10% end-systolic left ventricular volume reduction at 3-months of follow-up (data
presented as mean value with standard deviation (SD) or number of patients with the percentage share (%) of the
whole analysed group or subgroup, p – value for comparison between responders and non-responders)
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LVESV reduction in the follow-up were included: an
ischaemic aetiology of CHF, permanent atrial
fibrillation, prevalence of hypertension, hypotension
and N-terminal pro-B-type natriuretic peptide 
(NT-proBNP) concentration [16]. Also left bundle
branch block (LBBB) and non-LBBB morphology of
QRS complex were considered. The predictive
values of Tstrain of 12 LV segments and TTDI basal 
LV-RV regarding LVESV reduction lost their statistical
significance.
Discussion
Significance of response to CRT criteria choice.
Rationale for the magnitude of LVESV reduction
assessment as CRT outcome measure
Response to CRT criteria hugely influence study
results. Moreover, response to CRT rates differ
dramatically depending on the applied definition.
Compiling data from the literature suggest that
reversal of the maladaptive left ventricle remodelling
Parameter Before CRT (n = 57) 3 months after CRT (n = 57) Value of p
NYHA 3.1 (0.2) 2.2 (0.7) < 0.001
6-MWT [m] 298.0 (107.4) 373.1 (127.1) < 0.001
LVEDd [mm] 73.3 (8.9) 71.5 (9.8) 0.003
LVESd [mm] 62.4 (10.0) 60.6 (11.3) 0.034
LVEDV [ml] 244.3 (83.8) 226.4 (88.6) 0.002
LVESV [ml] 192.8 (71.9) 168.7 (76.5) < 0.001
SV [ml] 51.5 (16.6) 57.7 (16.9) < 0.001
LVEF [%] 21.7 (4.8) 26.0 (4.8) < 0.001
NT-proBNP [pg/ml] 2387.2 (1836.1) 1844.5 (1312.3) 0.027
QRS width 184.2 (28.3) 152.7 (19.1) < 0.001
NYHA – New York Heart Association functional class, 6-MWT – 6-min walk test distance, LVEDd – left ventricular end-diastolic diameter, LVESd
– left ventricular end-systolic diameter, LVEDV – left ventricular end-diastolic volume, LVESV – left ventricular end-systolic volume, SV – stroke
volume, LVEF – left ventricular ejection fraction, NT-proBNP – N-terminal pro-B-type natriuretic peptide
Table II. Clinical and echocardiographic parameters in the study group before and 3 months after CRT introduction
Parameter Responders, n = 34 (59.6%) Non-responders, n = 23 (40.4%)
Initially After 3 months Value of p Initially After 3 months Value of p
LVEDd [mm] 73.2 (7.4) 69.9 (8.3) < 0.001 73.5 (10.9) 73.9 (11.5) 0.47
LVESd [mm] 62.0 (7.9) 58.1 (9.4) 0.003 63.0 (12.7) 64.2 (13.0)* 0.13
LVEDV [ml] 246.3 (61.1) 209.5 (58.7) < 0.001 241.3 (110.7) 251.4 (117.6) 0.054
LVESV [ml] 194.5 (55.9) 153.0 (51.4) < 0.001 190.3 (92) 191.8 (99.9) 0.68
SV [ml] 51.6 (12.8) 56.3 (12.4) 0.002 51.4 (21.3) 59.6 (22.2) 0.002
MR [%] 25.6 (14) 18.4 (11) 0.001 23.7 (11) 24.4 (11) 0.62
QRS [ms] 179 (28) 153 (20) 0.001 199 (27) 152 (17) 0.001
LVEF [%] 21.5 (4.9) 27.1 (4.8) < 0.001 21.9 (4.7) 24.5 (4.7)* 0.003
6-MWT [m] 315.7 (112.1) 392.3 (109.5) < 0.001 271.9 (96) 344.7 (147.4) 0.001
NYHA 3.1 (0.3) 2.1 (0.5) < 0.001 3.1 (0.2) 2.5 (0.8) 0.001
NT-proBNP [pg/ml] 2005.6 1512.0 0.012 3150.5 2509.5 0.32
(1632.3) (1148.7) (2034.3)# (1403.6)*
VV-sep [cm] 8.1 (2.9) 8.9 (2.3)
6-MWT – 6-min walk test distance, LVEDd – left ventricular end-diastolic diameter, LVEDV – left ventricular end-diastolic volume, LVEF – left
ventricular ejection fraction, LVESd – left ventricular end-systolic diameter, LVESV – left ventricular end-systolic volume, MR – mitral regurgitation
– presented as % of left atrium area, NT-proBNP – N-terminal pro-B-type natriuretic peptide, NYHA – New York Heart Association Functional
Classification, VV-sep. – right and left ventricular electrode tips’ separation on sagittal chest X-ray 
Each parameter is presented as arithmetic mean with standard deviation (SD), p – for the difference between initial and after 3-month follow-
up values of the same parameter, #p < 0.05 – for the difference between initial parameters of responders and non-responders, *p < 0.05 – for
the difference between parameters of responders and non-responders measured after 3 months of follow-up
Table III. Specialized examinations results of responders and non-responders according to the applied criterion 
of at least 10% end-systolic left ventricular volume reduction at 3-month follow-up
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mechanism in CHF observed a few months after CRT
implementation is the best predictor of positive
long-term outcome. Yu et al. showed in a series of
141 CRT patients that reduction of LVESV of at least
10% was related to a very low event rate (6.9% all-
cause mortality) in a mean follow-up period of 695
days [9]. Di Biase et al. in an analysis from
a prospective registry including 398 consecutive
patients, with the median duration of follow-up of
4.4 years, demonstrated that the magnitude of
reverse remodelling measured by LVEF and LVESV
after 3 months of CRT implementation irrespectively
of aetiology predicted outcome [10]. 
Methodological considerations 
Our analyses of the colour-coded TDI velocities,
strain and strain rate curves were not restrained to
the ejection period. This common practice distorts
dyssynchrony imaging since contraction of certain
left ventricle parts takes place not only during the
ejection phase but also before opening and after
the aortic valve closure. Such velocities may be
greater than the ejection peaks and need to be
distinguished from passive tethering by the
adjoining myocardial segments. Both these
movements are interchangeably classified by
different authors as the phenomenon of post-
systolic shortening/thickening (PSS). The PSS is
therefore commonly observed in patients
undergoing CRT, was found to be of high sensitivity
in detecting ischaemia in other studies, but might
be present even in one third of left ventricle
segments in healthy individuals [18]. A problem also
arises when fine tuning of the myocardial region of
interest during TDI analysis fails to produce a single
Parameter All Responders Non-responders Value of p
Colour-coded TDI
TTDI-SD 58.0 (16) 54.8 (18) 62 (12.8) 0.14
TTDI-12 176.2 (54) 165.8 (62) 189.1 (41) 0.15
TTDI-6-basal 153.2 (96) 159.5 (111) 143.8 (66) 0.55
TTDI-IVS-free wall 222.8 (181) 200 (180) 258.3 (183) 0.29
TTDI-basal IVS-free wall 130.9 (88) 126.8 (85) 137.4 (96) 0.69
TTDI-IVD 59.4 (46) 49.5 (40) 73.7 (51) 0.06
Strain
Tstrain-SD 125.2 (33) 131.83 (30) 115.6 (36) 0.09
Tstrain-12 414.6 (111) 441.9 (114) 367.7 (89) 0.023
Tstrain-6-basal 318.9 (109) 342.2 (108) 287.5 (106) 0.09
Tstrain-IVS-free wall 391.2 (243) 405.9 (228) 495.3 (269) 0.60
Tstrain-basal IVS-free wall 210.7 (139) 229.0 (141) 180 (135) 0.22
Tstrain-IVD 169.3 (103) 161.5 (100) 179.5 (108) 0.56
Strain rate
Tstrain rate-SD 133.4 (29) 140.6 (27) 124.7 (31) 0.06
Tstrain rate-12 403.8 (98) 418.3 (100) 384.1 (94) 0.22
Tstrain rate-6-basal 341.9 (78) 359.6 (68) 318 (87) 0.07
Tstrain rate-IVS-free wall 454.7 (283) 494.1 (306) 395.5 (242) 0.25
Tstrain rate-basal IVS-free wall 243.6 (144) 271.7 (141) 192.5 (140) 0.08
Tstrain rate-IVD 169.2 (116) 177.5 (124) 158.6 (108) 0.58
T-SD – standard deviation of time from the beginning of QRS complex to maximum systolic velocity/strain/strain rate in 12 left ventricle segments,
T-12 – maximum difference of time from the beginning of QRS complex to maximum systolic velocity/strain/strain rate among 12 left ventricle
segments (basal and midlevel), T-6-basal – maximum difference of time from the beginning of QRS complex to maximum systolic
velocity/strain/strain rate among 6 basal left ventricle segments, T-IVS- free wall – maximum difference of time from the beginning of QRS
complex to maximum systolic velocity/strain/strain rate between basal and midlevel septal segments (septal and antero-septal segments) and
left ventricle free wall (lateral and posterior segments), T-basal IVS-free wall – maximum difference of time from the beginning of QRS complex
to maximum systolic velocity/strain/strain rate between basal septal segments (septal and antero-septal segments) and left ventricle free wall
(lateral and posterior segments), T-IVD – maximum difference of time from the beginning of QRS complex to maximum systolic velocity/strain/strain
rate between basal left ventricle and right ventricle segments
Table IV. Baseline parameters [ms] of mechanical dyssynchrony assessed with colour-coded tissue Doppler imaging
(TDI), myocardial strain and strain rate in the whole study group, responders and non-responders according to the
applied criterion of at least 10% end-systolic left ventricular volume reduction at 3-month follow-up
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reproducible peak. Strategies of proceeding in such
situations varied in different studies, and the ASE
recommendation of choosing the earlier peak if two
or more peaks are of the same height is also
challenged. In our research multi-peak curves with
comparable maximal height were excluded from
the analysis. As described in the ‘material and
methods’ section, using the quality experience of
previous studies, the offline calculations were
performed by one experienced physician with the
variability of the studied TDI, strain and strain rate
parameters not exceeding 10%, which has to be
considered as an attribute of this paper [19, 20].
One of our study assumptions was to provide
information useful for typical CHF patients
undergoing CRT. It is crucial to remember that,
although presence of permanent atrial fibrillation
is believed to predict poorer outcome, the huge
meta-analysis of Upadhyay et al. of 1,164 CRT
individuals indicates that the strategy, undertaken
also in our study, of ventricles’ rate control with 
β-blockers, digoxin and amiodarone and, if
ineffective, ablation of the atrioventricular node
confers a benefit similar to that of CRT to the group
of patients in sinus rhythm [2, 21]. Despite
reservations about the accuracy of echocardio -
graphic analysis in atrial fibrillation patients, some
researchers appreciate the significance of mecha -
nical dyssynchrony in this group and successfully
apply its quantification in their studies [22, 23]. 
Efficiency of colour-coded TDI derived indices
of baseline dyssynchrony and interventricular
dyssynchrony appraisal 
The largest body of literature and the principal
method in clinical use to quantify mechanical
dyssynchrony in CHF patients undergoing CRT is
Parameter Value of r Value of p
Colour-coded TDI
TTDI-SD –0.05 0.72
TTDI-12 –0.07 0.63
TTDI-6-basal –0.03 0.80
TTDI-IVS-free wall –0.16 0.28
TTDI-basal IVS-free wall –0.04 0.76
TTDI-IVD –0.29 0.041
Strain
Tstrain-SD 0.18 0.24
Tstrain-12 0.34 0.017
Tstrain-6-basal 0.21 0.16
Tstrain-IVS-free wall 0.15 0.30
Tstrain-basal IVS-free wall 0.07 0.64
Tstrain-IVD 0.05 0.76
Strain rate
Tstrain rate-SD 0.19 0.19
Tstrain rate-12 0.20 0.16
Tstrain rate-6-basal 0.14 0.34
Tstrain rate-IVS-free wall 0.15 0.33
Tstrain rate-basal IVS-free wall 0.08 0.60
Tstrain rate-IVD 0.03 0.81
Table V. Correlation between the magnitude of LVESV
reduction [ml] following CRT introduction and initial
parameters of mechanical dyssynchrony [ms]
assessed with colour-coded tissue Doppler imaging
(TDI), myocardial strain and strain rate in the whole
study group
Abbreviations – see Table IV
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Figure 1. Correlation between the magnitude of LVESV reduction following CRT introduction and initial parameters
of mechanical dyssynchrony: A – TTDI basal LV-RV segments, B – Tstrain of 12 LV segments
TTDI basal LV-RV segments – maximum difference of time from the beginning of QRS complex to maximum systolic velocity between
basal left ventricle and right ventricle segments, Tstrain-12 – maximum difference of time from the beginning of QRS complex to maximum
systolic strain among 12 left ventricle segments
A B
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represented by the assessment of longitudinal left
ventricle shortening velocities using colour-coded
TDI from the apical window [15]. We found no
significant correlation of the analysed colour-coded
TDI parameters of intraventricular dyssynchrony
with LVESV reduction. Similar results come from
other studies on correlations of TDI baseline indices
with LVESV volume changes after CRT. Miyazaki et
al. failed to demonstrate the usefulness of septal-
lateral, anteroseptal-posterior delay and TTDI-SD in
a median 6-month-follow-up [24]. Phillips et al.
found no predictive value of septal-lateral delay [25]. 
The interventricular dyssynchrony assessed with
maximal difference between time from the
beginning of QRS complexes to the peak velocity
of basal LV and RV segments correlated negatively,
indicating that the smaller the initial difference the
more pronounced the reverse remodelling after CRT,
which is quite an interesting finding. The
echocardiographic assessment of interventricular
dyssynchrony in previous studies on CRT was
mainly based on the interventricular mechanical
delay index (IVMD). The IVMD, reproducible and
easily calculated in daily practice had little efficacy
in predicting response to CRT as compared to
intraventricular dyssynchrony assessment [26-29].
It should also be noted that evaluation of
interventricular dyssynchrony with TDI and
evaluation with IVMD represent different
phenomena of heart performance: TDI, the
movement of heart muscle parts; IVMD, the blood
flow. The timing of the ejection of blood out of
ventricles is conditioned by many factors including
valves’ and right ventricle function, different
haemodynamic states, pulmonary diseases, etc.,
and poorly reflects the synchrony of myocardial
contraction. The role of interventricular dyssyn -
chrony and the optimal approach to the issues of
TDI parameters are yet to be clarified.
Advantage of myocardial strain calculation.
Strain rate imaging inapplicable
Strain and strain rate imaging, thought to be
unaffected by movement of structures in the
thorax, adjoining parts of heart muscle or the
location in the ventricle, have the theoretic
advantage of differentiating active myocardial con -
traction from passive translational movement [30].
Unfortunately, they are difficult to calculate in
spherical LV geometry common in CHF, their
application requires proper training and experience
of the operator as well as good quality images, and
they have disputable reproducibility [15]. 
Advantages of strain imaging in the prediction
of CRT outcome were emphasized by some
researchers [31-33]. Breithardt et al. concluded that
the degree of dyssynchrony was not accurately
represented by the timing of myocardial velocity,
especially in ischaemic heart disease, and proposed
that the timing of deformation should be the
preferred modality [31]. Sogaard et al. found that
the extent of delayed longitudinal contraction at
the base predicted LVEF increase following CRT [32,
33]. In our study the only strain parameter that
differentiated responders from non-responders and
correlated with the magnitude of LVESV reduction
was Tstrain-12. In the aforementioned study of
Miyazaki, baseline Tstrain-SD showed a significant
correlation with the percent reduction in LVESV at
the follow-up (r = 0.57, p < 0.001) [24]. This supports
the idea of eliciting the sites of the earliest and the
latest activation with the strain imaging technique. 
Parameters of strain rate in our study were not
related to the change of LVESV. This is coherent
with the ASE report based on the series of the
studies of Yu et al., who failed to demonstrate the
usefulness of strain rate imaging to predict the LV
reverse remodelling response to CRT [34, 35]. 
The multivariate analysis showed that the
predictive significance of dyssynchrony appraisal is
lost when other variables are taken into account. This
emphasizes the role of complex evaluation of po -
tential CRT recipients including a broad array of con -
ditions associated with poor prognosis in CHF [1].
Our study group, after inclusion of patients with
atrial fibrillation and the group of pacemakers
upgraded to CRT, was heterogeneous but highly
reflected the clinical profile of patients undergoing
biventricular stimulator implantation in daily
practice. Recording myocardial walls separately
reduced Doppler angle dependent bias in
calculating echocardiographic parameters, but
caused that analysed curves, though always at least
3 were considered, came from different heart cycles. 
The study had a non-randomized design, the
sample size was small and the observational period
was relatively short. Clinical and heart performance
changes elicited by CRT may not always appear
simultaneously and patients who present with
clinical effects may not exhibit echocardiographic
improvement and vice versa; thus longer follow-up
would definitely provide accessory information about
the significance of left ventricle reverse remodelling
noted 3 months after CRT introduction [36].
In conclusion, only a few TDI-derived parameters
such as maximum time difference from the
beginning of QRS complex to maximum strain
among 12 basal and midlevel left ventricular
segments or maximum time difference from the
beginning of QRS complex to maximum myo -
cardium velocity in colour-coded TDI between left
and right ventricular basal segments can be useful
to predict the magnitude of left ventricle reverse
remodelling after CRT introduction. The predictive
value of the parameters is limited when other
clinical and biochemical factors are considered.
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